Skip to main content
. 2014 Feb 3;3(2):e85. doi: 10.1038/oncsis.2013.49

Figure 6.

Figure 6

DNA-PKcs deficiency renders cells resistant to paclitaxel. (a) HCT116 and DNA-PKcs−/− cells were treated with indicated concentrations of paclitaxel and were analyzed for clonal survival ability. (b) HCT116 and DNA-PKcs−/− cells were treated with paclitaxel for 72 h, and viability was determined using an MTT assay. ***P<0.001; ****P<0.0001.